33 results
Thumbnail

D1.233 - Pembrolizumab IgE mediated drug hypersensitivity reaction and successful desensitisation

Thumbnail

D1.234 - The Importance of Differential Diagnosis in DRESS Syndrome: Review of 2 Cases

Thumbnail

D1.235 - Clorhexidine allergy in northern area of Seville

Thumbnail

D1.236 - Clinical Outcomes of Neuromuscular Blocking Agent Rechallenge Based on Skin Prick Test in Patients with Intraoperative Anaphylaxis

Thumbnail

D1.237 - What Do Drug Skin Tests Tell Us About Quinolone Allergy? Adult Allergy Reference Center Experience

Thumbnail

D1.238 - Urgent desensitization to amiodarone

Thumbnail

D1.239 - Nonsteroidal anti-inflammatory drug cross-hypersensitivity phenotypes show high carbonyl levels

Thumbnail

D1.243 - L-asparaginase desensitization in children

Thumbnail

D1.244 - Retrospective Analysis of Adverse Reactions to Iodinated Contrast Media: Experience in 165 Patients

Thumbnail

D1.245 - Platinum salt hypersensitivity: Experience of our Center

Thumbnail

D1.246 - Cephalosporin Allergy in Children

Thumbnail

D1.247 - Tolerance to intravenous sodium heparin despite a positive subcutaneous challenge test: A case report

Thumbnail

- D3.100 - Risk Factors and Biomarkers for COVID-19 and Allergic Diseases

Thumbnail

- D3.102 - PROMs Improvement Effects of Biologics in Chronic Rhinosinusitis with Nasal Polyps Patients: Real-life Experience

Thumbnail

- D3.103 - Impact of aspirin-induced bronchospasm on the in vitro Aspirin Hypersensitivity Diagnostic Index in the patients with Aspirin Exacerbated Respiratory Disease

Thumbnail

- D3.104 - A step towards standardized Clinical Remission Criteria for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP): insights from a real-life study

Thumbnail

- D3.105 - Suspected EGPA in a patient on Dupilumab treatment: confirmed diagnosis of sarcoidosis - case report

Thumbnail

- D3.106 - Real-World Dupilumab Effectiveness Through 18 Months in Patients with CRSwNP and Coexisting Asthma: Results from the Global AROMA Registry

Thumbnail

- D3.108 - PTGDR2 Blood Expression as a Potential Biomarker for Predicting Super-Response to IL-5-Targeted Therapies in Severe Asthma

Thumbnail

D3.109 - Lichen planus following dupilumab treatment in patients with severe asthma and nasal sinus polyposis